Alzheimer’s Disease Neuroimaging Initiative Selected Research

Secondary Prevention

8/2022	Imminent cognitive decline in normal elderly individuals is associated with hippocampal hyperconnectivity in the variant neural correlates of episodic memory.
10/2020	Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease.
1/2018	MRI-Based Screening of Preclinical Alzheimer's Disease for Prevention Clinical Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alzheimer’s Disease Neuroimaging Initiative Research Topics

Disease

604	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 09/2010
335	Cognitive Dysfunction 04/2024 - 09/2010
159	Dementia (Dementias) 05/2024 - 01/2012
118	Atrophy 04/2024 - 01/2012
60	Disease Progression 04/2024 - 01/2012
30	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 10/2016
15	Genetic Risk Score 05/2024 - 01/2017
14	Inflammation (Inflammations) 06/2023 - 01/2020
12	Amyloidosis 01/2022 - 01/2015
10	Amyloid Plaque 04/2024 - 12/2012
9	Tauopathies 11/2023 - 01/2017
8	Neuroinflammatory Diseases 06/2023 - 01/2015
7	Hypertension (High Blood Pressure) 08/2023 - 01/2015
7	Cerebral Cortical Thinning 01/2023 - 09/2015
6	Prodromal Symptoms 02/2020 - 07/2014
5	Genetic Predisposition to Disease (Genetic Predisposition) 05/2024 - 01/2017
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023 - 01/2017
5	Parkinson Disease (Parkinson's Disease) 05/2022 - 01/2013
4	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 06/2013
4	Obesity 01/2023 - 01/2013
3	Brain Diseases (Brain Disorder) 03/2024 - 12/2017
3	Pathologic Processes 01/2023 - 10/2019
3	Insulin Resistance 01/2023 - 01/2017
3	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2022 - 08/2017
3	Proteostasis Deficiencies 01/2021 - 01/2017
3	Infarction (Infarctions) 01/2020 - 10/2011
2	Cerebral Small Vessel Diseases 02/2024 - 01/2022
2	Hallucinations (Hallucination) 01/2024 - 11/2023
2	Lewy Body Disease (Lewy Body Dementia) 10/2023 - 01/2017
2	Body Weight (Weight, Body) 01/2023 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 01/2023
2	Neurobehavioral Manifestations 11/2022 - 10/2014
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
2	Frailty 01/2021 - 01/2020
2	Weight Loss (Weight Reduction) 01/2020 - 01/2018
2	Brain Injuries (Brain Injury) 02/2019 - 11/2015

Drug/Important Bio-Agent (IBA)

378	Biomarkers (Surrogate Marker)IBA 05/2024 - 09/2010
308	Amyloid (Amyloid Fibrils)IBA 05/2024 - 10/2011
109	Apolipoproteins E (ApoE)IBA 04/2024 - 03/2012
52	ApolipoproteinsIBA 01/2024 - 06/2012
46	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 12/2012
45	Amyloid beta-PeptidesIBA 04/2024 - 12/2012
40	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2011
40	florbetapirIBA 12/2023 - 01/2013
27	Apolipoprotein E4IBA 05/2024 - 01/2015
20	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2024 - 01/2019
16	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 02/2013
13	tau Proteins (tau Protein)IBA 12/2023 - 01/2018
10	Peptides (Polypeptides)IBA 12/2023 - 01/2012
9	Indicators and Reagents (Reagents)IBA 10/2023 - 10/2016
7	Cholinergic Agents (Cholinergics)IBA 02/2024 - 12/2016
7	Complement System Proteins (Complement)IBA 01/2024 - 01/2016
7	LipidsIBA 06/2023 - 10/2013
6	SynucleinsIBA 01/2023 - 01/2013
6	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2023 - 01/2020
6	NeurograninIBA 01/2022 - 11/2015
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2024 - 09/2015
5	GAP-43 Protein (GAP 43 Protein)IBA 01/2024 - 01/2022
5	CholesterolIBA 01/2023 - 05/2012
4	Genetic Markers (Genetic Marker)IBA 03/2023 - 01/2015
4	Threonine (L-Threonine)FDA Link 01/2023 - 01/2021
4	HomocysteineIBA 01/2023 - 01/2015
4	LeptinIBA 11/2022 - 01/2013
4	Insulin-Like Growth Factor Binding Protein 2IBA 01/2022 - 01/2013
3	Insulin (Novolin)FDA Link 05/2024 - 01/2013
3	Cerebrospinal Fluid ProteinsIBA 12/2023 - 09/2014
3	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2023 - 01/2018
3	Insulin-Like PeptidesIBA 01/2023 - 12/2017
3	AdiponectinIBA 11/2022 - 01/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2020
3	LigandsIBA 01/2022 - 01/2020
3	Blood Proteins (Serum Proteins)IBA 01/2022 - 10/2013
3	CytokinesIBA 01/2022 - 01/2013
3	EnzymesIBA 10/2019 - 01/2016
3	Blood Glucose (Blood Sugar)IBA 01/2019 - 01/2017
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2014 - 01/2012
2	Cell Adhesion MoleculesIBA 02/2024 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2023 - 10/2013
2	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2023 - 01/2021
2	ElementsIBA 01/2023 - 09/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 01/2022
2	Hormones (Hormone)IBA 01/2023 - 01/2017
2	Interleukin-3 (Interleukin 3)IBA 12/2022 - 01/2022
2	C-Reactive ProteinIBA 12/2022 - 07/2021
2	Apolipoprotein E3IBA 01/2022 - 01/2022
2	IronIBA 01/2022 - 01/2017
2	AZD4694IBA 10/2021 - 01/2021
2	RadiopharmaceuticalsIBA 01/2021 - 03/2020
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021 - 11/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
2	PrionsIBA 01/2021 - 10/2020
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2018
2	FibrinIBA 01/2020 - 01/2016
2	Sex Hormone-Binding GlobulinIBA 01/2020 - 01/2017
2	Pemetrexed (MTA)FDA Link 09/2019 - 12/2017

Therapy/Procedure

16	Therapeutics 05/2024 - 01/2012
8	Activities of Daily Living (ADL) 01/2023 - 01/2017
3	Precision Medicine 04/2024 - 01/2022
3	Secondary Prevention 08/2022 - 01/2018